Open AccessAN OBSERVATIONAL CROSS-SECTIONAL STUDY ON THE NEUROPSYCHIATRIC MANIFESTATIONS OF COVID-19 PANDEMIC IN SUSPECTED AND POSITIVE PATIENTS IN NORTHERN INDIA
Author(s) -
Harish Basera,
K. C. Pant,
JS Bisht
Publication year - 2021
Publication title -
journal of medical pharmaceutical and allied sciences
Language(s) - English
Resource type - Journals
ISSN - 2320-7418
DOI - 10.22270/jmpas.v10i4.1408
Subject(s) - lethargy , depression (economics) , anxiety , observational study , medicine , mood , delirium , mental health , psychiatry , pandemic , grief , covid-19 , disease , infectious disease (medical specialty) , economics , macroeconomics
Psychotherapy and grief reduction have been the mainstays of mental health care. Mental health on the other hand, is distinct from the lack of ‘Mental Illness in that it encompasses psychological, social, and psychological wellbeing. The purpose of this study is to assess the Hamilton Depression Rating in COVID-19 patients in a tertiary care facility in Northern India. An observational study of Covid-19 positive individuals hospitalized to a tertiary healthcare centre in northern India was conducted. Over the course of six months, 1040 Covid-19 positive/ suspected individuals were enrolled in this study. The HDRS (Hamilton Rating Scale for Depression) was designed with hospital patients in mind, stressing the physical signs and symptoms of depression. The HAM-D scale is used to assess the severity of depression in patients with Covid-19. Despite the fact that there are 21 sections, the patient's score is based on the first 17 responses. During the six-month research period, a total of 1040 covid-19 suspected and positive patients were admitted. There were 240 covid-19 positive patients and 800 covid-19 suspicious patients out of a total of 1040. In positive patients, anxiety was present in 95.83 percent, mood change in 55 percent, and fear of death 23.33 percent; in suspected covid-19 patients, anxiety was present in 57 percent, mood alteration in 19 percent, and fear of death 13.5 percent. According to current research, severe COVID-19 may produce delirium in the acute stage of disease, followed by depression, anxiety, lethargy, insomnia, and post-traumatic stress disorder (PTSD) in the long term.